$108.09
0.50[0.46%]
At close: Apr 23
$108.09
0[0.00%]
PreMarket: 5:22PM EDT
Abbott Laboratories
(NYSE:ABT)Latest News for Abbott Laboratories Stock (NYSE:ABT)
Abbott Laboratories Stock (NYSE: ABT)
Categories: All
Monday, April 22, 2024
Thursday, April 18, 2024
Wednesday, April 17, 2024
- Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?Piero Cingari - 6 days ago
- Abbott shares are trading lower following Q1 earnings.Benzinga Newsdesk - 6 days ago
- Dow Surges 200 Points; Abbott Laboratories Posts Upbeat EarningsAvi Kapoor - 6 days ago
- Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual GuidanceVandana Singh - 6 days ago
- Abbott Forecasts Q2 2024 Adjusted EPS Of $1.08-$1.12 Versus Consensus Of $1.12Benzinga Newsdesk - 6 days ago
- Abbott Revises 2024 Adjusted EPS Guidance To $4.55-$4.70 Versus Prior Guidance Of $4.50-$4.70 And Consensus Of $4.62Benzinga Newsdesk - 6 days ago
- Abbott Laboratories Q1 2024 Adj EPS $0.98 Beats $0.95 Estimate, Sales $9.964B Beat $9.880B EstimateBenzinga Newsdesk - 6 days ago
- Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry PointShanthi Rexaline - 6 days ago
- Earnings Scheduled For April 17, 2024Benzinga Insights - Apr 17, 2024, 5:15AM
- Investor Optimism Decreases; Dow Ends 6-Session Losing StreakAvi Kapoor - Apr 17, 2024, 2:06AM
- Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into WednesdayAvi Kapoor - Apr 17, 2024, 2:06AM
Monday, April 15, 2024
Friday, April 12, 2024
Thursday, April 11, 2024
Tuesday, April 09, 2024
Thursday, April 04, 2024
Wednesday, April 03, 2024
Tuesday, April 02, 2024
Monday, April 01, 2024
Thursday, March 28, 2024
Wednesday, March 27, 2024
Tuesday, March 19, 2024
Friday, March 15, 2024
Friday, March 08, 2024
Wednesday, March 06, 2024
- FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott'sVandana Singh - Mar 6, 2024, 4:48PM
- Abbott Annonuces Data From Two Real-World Studies Showing People With Type 2 Diabetes Using GLP-1 Medicines Saw Improvement In Their HbA1C After Adding Freestyle Libre Technology To Their RegimenBenzinga Newsdesk - Mar 6, 2024, 9:03AM
Tuesday, March 05, 2024
- Sell Alert: John A. McCoy Jr. Cashes Out $55K In Abbott Laboratories StockBenzinga Insights - Mar 5, 2024, 10:02AM
- Executive Vice President Of Abbott Laboratories Sold $94K In StockBenzinga Insights - Mar 5, 2024, 10:02AM
- Massive Insider Trade At Abbott LaboratoriesBenzinga Insights - Mar 5, 2024, 10:02AM
Friday, March 01, 2024
Monday, February 26, 2024
Friday, February 23, 2024
Tuesday, February 20, 2024
Wednesday, February 14, 2024
- Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair DeviceVandana Singh - Feb 14, 2024, 12:47PM
- RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $128 Price TargetBenzinga Newsdesk - Feb 14, 2024, 9:50AM
- Reported Late Tuesday, FDA Advisory Committee Votes In Favor Of Abbott's First-of-Its-Kind TriClip™ System To Treat People With A Leaky Tricuspid Heart ValveBenzinga Newsdesk - Feb 14, 2024, 1:25AM